Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: Possible involvement of GABA in mediating the effects

Neuroscience

Volumn 115, Issue 2, 2002, Pages 603-612

  Seto, D ^a   Zheng, W H ^a,b   McNicoll, A ^b   Collier, B ^b   Quirion, R ^a,b   Kar, S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Acetylcholine; Choline transport; GABA; Insulin like growth factor I; Neurotransmitter release

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYLCHOLINESTERASE; BACLOFEN; BICUCULLINE; MUSCIMOL; SODIUM CHANNEL; VERATRIDINE;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; BRAIN SLICE; CENTRAL NERVOUS SYSTEM; CHOLINE UPTAKE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG INHIBITION; ENZYME ACTIVITY; EVOKED RESPONSE; FEMALE; HIPPOCAMPUS; IN VITRO STUDY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM;

ACETYLCHOLINE; ANIMALS; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; ENZYME ACTIVATION; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR I; MALE; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 1; SYNAPTIC TRANSMISSION; TRITIUM;

EID: 0037146705     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00450-5     Document Type: Article

References (80)

1. Aberg M.A.I., Aberg N.D., Hedbacker H., Oscarsson J., Eriksson P.S. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 20:2000;2896-2903.
2. Adamo M., Raizada M.K., LeRoith D. Insulin and insulin-like growth factor receptors in the nervous system. Molec. Neurobiol. 3:1989;71-100.
3. Aizeman Y., De Vellis J. Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation. Brain Res. 406:1987;32-42.
4. B receptors differentially regulate striatal acetylcholine release in vivo. Neurosci. Lett. 160:1993;126-130.
5. Araujo D.M., Lapchak P.A., Collier B., Chabot J.G., Quirion R. Insulin-like growth factor-I (somatomedin-C) receptors in the rat brain: distribution and interaction with hippocampal cholinergic system. Brain Res. 484:1989;130-138.
6. Bassant M.H., Jobert A., Dutar P., Lamour Y. Effects of psychotropic drugs on identified septohippocampal neurons. Neuroscience. 27:1988;911-920.
7. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., Hefti F. IGF-I gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14:1995;717-730.
8. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1981;1279-1281.
9. Bland B.H., Trepel C., Oddie S.D., Kirk I.J. Intraseptal injections of muscimol: effects on hippocampal formation theta rhythm and phasic theta-on cell discharges. Exp. Neurol. 138:1996;286-297.
10. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz D.P., Dorsa D.M., Baskin D.G. Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res. 444:1988;205-213.
11. Bondy C., Werner H., Roberts C.T., LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience. 46:1992;909-924.
12. Breese C.R., D'costa A., Rollins Y.D., Adams C., Booze R.M., Sonntag W.E., Leonard S. Expression of insulin-like growth factor-1 (IGF-1) and IGF-binding protein 2 (IGF-BP2) in the hippocampus following cytotoxic lesion of the dentate gyrus. J. Comp. Neurol. 369:1996;388-404.
13. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., LeRoith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. 121:1998;19-26.
14. Carro E., Nunez A., Busiguina S., Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J. Neurosci. 20:2000;2926-2933.
15. Carson M.J., Behringer R.R., Brinster R.L., McMorris F.A. Insulin-like growth factor-I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 10:1993;729-740.
16. Castro-Alamancos M.A., Arevalo M.A., Torres-Aleman I. Involvement of protein kinase C and nitric oxide in the modulation by insulin-like growth factor-I of glutamate-induced GABA release in the cerebellum. Neuroscience. 70:1996;843-847.
17. Castro-Alamancos M.A., Torres-Aleman I. Long-term depression of glutamate-induced γ-aminobutyric acid release in cerebellum by insulin-like growth factor I. Proc. Natl. Acad. Sci. USA. 90:1993;7386-7390.
18. Cheng B., Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1992;1558-1566.
19. Cheng C.M., Joncas G., Reinhardt R.R., Farrer R., Quarles R., Janssen J., McDonald M.P., Crawley J.N., Powell-Braxton L., Bondy C.A. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. J. Neurosci. 18:1998;5673-5681.
20. Chrobak J.J., Stackman R.W., Walsh T.J. Intraseptal administration of muscimol produces dose-dependent memory impairments in the rat. Behav. Neur. Biol. 52:1989;357-369.
21. Collier, B. 1988. The synthesis and storage of acetylcholine in mammalian cholinergic nerve terminals. In: Avoli, M., Reader, T.A., Dykes, R.W., and Gloor, P., Eds., Neurotransmitters and Cortical Function: From Molecules to Mind. Plenum Press, New York, pp. 261-276.
22. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Rev. 27:1998;1-39.
23. De Pablo F.D., De la Rosa E.J. The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci. 18:1995;143-150.
24. Doré S., Kar S., Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20:1997;326-331.
25. Doré S., Kar S., Quirion R. IGF-I protects and rescues hippocampal neurons against β- amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. USA. 94:1997;4772-4777.
26. Durkin T. GABAergic mediation of indirect transsynaptic control over basal and spatial memory testing-induced activation of septo-hippocampal cholinergic activity in mice. Behav. Brain Res. 50:1992;155-165.
27. Fernandez A.M., de la Vega A.G., Torres-Aleman I. Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc. Natl. Acad. Sci. USA. 95:1998;1253-1258.
28. Fisone G., Wu C.F., Consolo S., Nordstrom O., Brynne N., Bartfai T., Melander T., Hokfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo and in vitro studies. Proc. Natl. Acad. Sci. USA. 84:1987;7339-7343.
29. Fonnum F. Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115:1969;465-472.
30. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry. 66:1999;137-147.
31. Frotscher M., Vida I., Bender R. Evidence for the existence of non-GABAergic, cholinergic interneurons in the rodent hippocampus. Neuroscience. 96:2000;27-31.
32. Garcia-Segura L.M., Perez J., Pons S., Rejas M.T., Torres-Aleman I. Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560:1991;167-174.
33. Giorgetti M., Bacciottini L., Giovannini M.G., Colivicchi M.A., Goldfarb J., Blandina P. Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats. Eur. J. Neurosci. 12:2000;1941-1948.
34. Givens B.S., Olton D.S. Cholinergic and GABAergic modulation of medial septal area: effects on working memory. Behav. Neurosci. 104:1990;849-855.
35. Gluckman P.D., Guan J., Beilharz E.J., Klempt N.D., Klempt M., Miller O., Sirimanne E., Dragunow M., Williams C.E. The role of insulin-like growth factor system in neuronal rescue. Ann. New York Acad. Sci. 692:1993;138-148.
36. Gorman L.K., Pang K., Frick K.M., Givens B., Olton D.S. Acetylcholine release in the hippocampus: effects of cholinergic and GABAergic compounds in the medial septal area. Neurosci. Lett. 166:1994;199-202.
37. Guan J., Williams C., Gunning M., Mallard E.C., Gluckman P.D. The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J. Cereb. Blood Flow Metab. 13:1995;609-616.
38. Guthrie K.M., Nguyen T., Gall C.M. Insulin-like growth factor-1 mRNA is increased in deafferented hippocampus: spatiotemporal correspondence of a trophic event with axon sprouting. J. Comp. Neurol. 352:1995;147-160.
39. B receptors in rat striatum. Brain Res. 816:1999;238-240.
40. Jafferali S., Dumont Y., Sotty F., Robitaille Y., Quirion R., Kar S. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus and cerebellum of normal human and Alzheimer's disease brains. Synapse. 38:2000;450-459.
41. Jhamandas J.H., Harris K.H., MacTavish D., Jassar B.S. Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease. J. Neurophysiol. 87:2002;696-704.
42. Jones J.I., Clemmons R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
43. 125I]insulin receptor binding sites in the rat hippocampal formation. Neuroscience. 55:1993;69-80.
44. 125I]insulin receptor binding sites in developing and adult rat brain. J. Comp. Neurol. 333:1993;375-397.
45. Kar S., Issa A.M., Seto D., Auld D.S., Collier B., Quirion R. Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J. Neurochem. 70:1998;2179-2187.
46. 125I]insulin receptor binding sites in adult rat hippocampal formation. Neuroscience. 80:1997;1041-1055.
47. Kar S., Seto D., Doré S., Hanisch U.-K., Quirion R. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the hippocampal formation. Proc. Natl. Acad. Sci. USA. 94:1997;14054-14059.
48. Knusel B., Michel P.P., Schwaber J.S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and insulin-like growth factor I and II. J. Neurosci. 10:1990;558-570.
49. Lee B.H., Lamour Y., Bassant M.H. Iontophoretic study of medial septal neurons in the unanesthetized rat. Neurosci. Lett. 128:1991;29-32.
50. Lee W.H., Clemens J.A., Bondy C.A. Insulin-like growth factors in the response to cerebral ischemia. Mol. Cell. Neurosci. 3:1992;36-43.
51. Lenoir D., Honegger P. Insulin-like growth factors I (IGF-I) stimulates DNA synthesis in fetal rat brain cell cultures. Dev. Brain Res. 7:1983;205-213.
52. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:1995;143-163.
53. Loddick S.A., Liu X.J., Lu Z.X., Liu C., Behan D.P., Chalmers D.C., Foster A.C., Vale W.W., Ling N., DeSouza E.B. Displacement of insulin-like growth factors from their binding proteins as a potential treatment of stroke. Proc. Natl. Acad. Sci. USA. 95:1998;1894-1988.
54. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1952;265-275.
55. McMorris F.A., Dubois-Daleq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21:1988;199-209.
56. Moor E., De Boer P., Westerink B.H.C. GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo. Eur. J. Pharmacol. 359:1998;119-126.
57. Mufson E.J., Kahl U., Bowser R., Mash D.C., Kordower J.H., Deecher D.C. Galanin expression within the basal forebrain in Alzheimer's disease. Ann. New York Acad. Sci. 863:1998;291-304.
58. Nakao N., Odin P., Lindvall O., Brundin P. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-I and neurotrophin-3 on striatal neurons in cultures. Exp. Neurol. 138:1996;144-147.
59. Nava F., Carta G., Bortolato M., Gessa G.L. Gamma-hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors. Eur. J. Pharmacol. 430:2001;261-263.
60. Niikura T., Hashimoto Y., Okamoto T., Abe Y., Yasukawa T., Kawasumi M., Hiraki T., Kita Y., Terashita K., Kouyama K., Nishimoto I. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein sensitive manner. J. Neurosci. 21:2001;1902-1910.
61. Nilsson L., Sara V.R., Nordberg A. Insulin-like growth factor-I stimulates the release of acetylcholine from rat cortical slices. Neurosci. Lett. 88:1988;221-226.
62. O'Kusky J.R., Ye P., D'Ercole A.J. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J. Neurosci. 22:2000;8435-8442.
63. O'Meara G., Coumis U., Ma S.Y., Kehr J., Mahoney S., Bacon A., Allen S.J., Holmes F., Kahl U., Wang F.H., Kearns I.R., Ove-Ogren S., Dawbarn D., Mufson E.J., Davies C., Dawson G., Wynick D. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc. Natl. Acad. Sci. USA. 97:2000;11569-11574.
64. Perry E.K. The cholinergic hypothesis: ten years on. Br. Med. Bull. 42:1986;63-69.
65. Quirion R. Cholinergic markers in Alzheimer's disease and the autoregulation of acetylcholine release. J. Psychiatry Neurosci. 18:1993;226-234.
66. Recio-Pinto E., Rechler M.M., Ishii D.N. Effects of insulin, insulin-like growth factor II and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J. Neurosci. 6:1986;1211-1219.
67. Sara V.R., Carlsson-Skwirut C. The role of insulin-like growth factors in the regulation of brain development. Prog. Brain Res. 73:1988;87-99.
68. Schneggenburger R., Lopez-Barneo J., Konnerth A. Excitatory and inhibitory synaptic currents and receptors in rat medial septal neurons. J. Physiol. 445:1992;261-276.
69. Segal M. Properties of rat medial septal neurons recorded in vitro. J. Physiol. 379:1986;309-330.
70. Seto D., Kar S., Quirion R. Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices. Br. J. Pharmacol. 120:1997;1151-1157.
71. Shemer J., Raizada M.K., Masters B.A., Ota A., LeRoith D. Insulin-like growth factor I receptors in neuronal and glial cells: characterization and biological effects in primary culture. J. Biol. Chem. 262:1987;7693-7699.
72. Tham A., Nordberg A., Grission F.E., Carlsson-Skwirut C., Viitanen M., Sara V. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer's type. J. Neural Transm. 5:1993;165-176.
73. Thompson S.M. Modulation of inhibitory synaptic transmission in the hippocampus. Prog. Neurobiol. 42:1994;575-609.
74. Tucek S. Regulation of acetylcholine synthesis in the brain. J. Neurochem. 44:1985;11-24.
75. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal and transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 8:1998;566-607.
76. Walsh T.J., Stackman R.W., Emerich D.F., Taylor L.A. Intraseptal injection of GABA and benzodiazepine receptor ligands alters high-affinity choline transport in the hippocampus. Brain Res. Bull. 31:1993;267-271.
77. Wecker L. The synthesis and release of acetylcholine by depolarized hippocampal slices is increased by increased choline available in vitro prior to stimulation. J. Neurochem. 57:1991;1119-1127.
78. White M.F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182:1998;3-11.
79. Wood P.L. Pharmacological evaluation of GABAergic inputs to the nucleus basalis-cortical and septal-hippocampal cholinergic projections. Can. J. Physiol. Pharmacol. 64:1986;325-328.
80. Zheng W.-H., Kar S., Quirion R. Stimulation of protein kinase C modulates insulin-like growth factor-1-induced Akt activation in PC12 cells. J. Biol. Chem. 275:2000;13377-13385.